Stay updated on ABBV-105/Upadacitinib Combo Follow-Up Clinical Trial
Sign up to get notified when there's something new on the ABBV-105/Upadacitinib Combo Follow-Up Clinical Trial page.

Latest updates to the ABBV-105/Upadacitinib Combo Follow-Up Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page’s footer/version indicator has been updated from **Revision: v3.5.2** to **Revision: v3.5.3**, reflecting a site update rather than a change to the clinical trial information.SummaryDifference0.0%

- Check25 days agoChange DetectedKrakow, Lesser Poland Voivodeship, Poland, 30-149 was replaced with Cracow, Lesser Poland Voivodeship, Poland, 30-149. The page revision changed from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check54 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 from the site records.SummaryDifference0.0%

- Check61 days agoChange Detected- Revision badge updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.0%

- Check90 days agoChange DetectedAdded Revision: v3.4.2. Removed the prior funding/operating-status notice (Revision: v3.4.1).SummaryDifference0.3%

- Check97 days agoChange DetectedAdded a government funding/status notice about the NIH Clinical Center and operations. Updated the site version from v3.4.0 to v3.4.1.SummaryDifference0.3%

Stay in the know with updates to ABBV-105/Upadacitinib Combo Follow-Up Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ABBV-105/Upadacitinib Combo Follow-Up Clinical Trial page.